SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
New ERA Energy & Digital, Inc. entered into an employment agreement with Darin Rovell effective June 22, 2026, appointing him as Chief Accounting Offi...
Astrotech Corporation has entered into an ATM offering agreement with H.C. Wainwright & Co., LLC dated June 2, 2026, allowing the company to sell shar...
Upbound Group increased the aggregate share authorization under its 2026 Long-Term Incentive Plan to 4,590,636 shares of common stock as of June 2, 20...
Intuitive Machines entered into a sales agreement with 10 financial institutions to sell up to $500 million of Class A common stock through an at-the-...
GEN Restaurant Group has appointed Luke Hewko as Chief Financial Officer effective June 1, 2026, with an annual salary of $300,000. The appointment ad...
# FDA Approves Generic Tofacitinib; Somerset Therapeutics Enters Competitive JAK Inhibitor Market Somerset Therapeutics, LLC has received FDA approva...
# FDA Approves Generic Tofacitinib from Novadoz Pharmaceuticals Novadoz Pharmaceuticals LLC has received FDA approval for its generic tofacitinib cit...
Sun Pharmaceutical Industries has received FDA approval for its generic tofacitinib citrate oral formulation, a regulatory milestone expected to drive...
Breckenridge Pharmaceutical’s FDA approval for oral tofacitinib citrate is set to introduce aggressive competition to the branded market, likely press...
Aurobindo Pharma received FDA approval for its generic tofacitinib citrate oral tablets on June 3, 2026, establishing a new entrant in the JAK inhibit...
Novadoz Pharmaceuticals secured FDA approval June 3, 2026, for oral Tofacitinib Citrate tablets, positioning the firm to capitalize on a significant r...
SpecGx LLC has received FDA approval for ANDA 219395, signaling an imminent opportunity for the company to enter the market with the companion diagnos...
Apotex has secured FDA approval for the generic version of tofacitinib (ANDA218096), slated for release on June 3, 2026, which is set to intensify com...
BriaCell Therapeutics filed a warrant agreement allowing placement agents to purchase common shares starting June 2, 2026, expiring five years later p...
Dorman Products commenced a private offering of $450 million in senior notes due 2034 to qualified institutional buyers, with proceeds designated for ...
Hallmark Venture Group assigned its promissory note from Traderverse Inc., which had a December 2025 balance of approximately $113,752 and was already...
Nauticus Robotics executed a third amendment to its loan agreement, modifying lender obligations and stockholder voting rights capped at 4.99% ownersh...
News Corporation announced a buyback program authorizing repurchase of up to $1 billion in aggregate of the company's Class A common stock. The share ...
Champion Homes announced leadership appointments of Wade Lyall as Chief Sales Officer, John Kastanek as Chief Customer Experience Officer, and Andrew ...
Nuo Therapeutics issued interim common stock purchase warrants dated May 29, 2026, exercisable through January 23, 2031, in connection with a Loan and...